Newark, DE, United States of America

Richard A Wildonger


Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 216(Granted Patents)


Location History:

  • Elmwood, DE (US) (1982 - 1991)
  • Morgan Hollow, PA (US) (1992)
  • Newark, DE (US) (1980 - 1998)

Company Filing History:


Years Active: 1980-1998

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Richard A. Wildonger

Introduction: Richard A. Wildonger is a prominent inventor based in Newark, Delaware, known for his significant contributions to the pharmaceutical field through his innovative work on peptide derivatives. With a remarkable portfolio of nine patents, Wildonger has demonstrated a strong commitment to advancing medical science.

Latest Patents: Among his latest patents, Richard A. Wildonger has developed peptide derivatives that are pharmaceutically useful as inhibitors of human leukocyte elastase. These inventions involve trifluoromethyl ketone substituted di-, tri-, and tetra-peptide derivatives, along with their respective salts. Additionally, his patents delve into aminoalcohol intermediates for these peptide derivatives, outlining processes and intermediates essential for the manufacturing of these compounds. His work not only improves understanding of these complex structures but also proposes potential therapeutic applications in medicine.

Career Highlights: Throughout his career, Richard has worked with notable companies in the chemical industry, including Ici Americas, Inc. and Imperial Chemical Industries Limited. His experience in these organizations has equipped him with the knowledge and expertise required to spearhead innovative projects and contribute to significant advancements in his field.

Collaborations: Richard has collaborated with several esteemed professionals throughout his career, including Diane A. Trainor and Philip D. Edwards. These collaborations have allowed him to enhance his research and expand the impact of his innovations, contributing to the development of effective pharmaceutical solutions.

Conclusion: Richard A. Wildonger's dedication to innovation and his extensive patent portfolio underscore his vital role in advancing pharmaceutical sciences. His work with peptide derivatives continues to hold promise for future medical applications, reflecting his commitment to improving healthcare through inventive solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…